An experimental HIV vaccine appears to have passed its first test in humans. In a newly released study, the vaccine candidate produced the sort of immune response that scientists had been hoping for in 97% of recipients. Importantly, the vaccine also seemed to be safe and well-tolerated.
An experimental HIV vaccine appears to have passed its first test in humans. In a newly released study, the vaccine candidate produced the sort of immune response that scientists had been hoping for in 97% of recipients. Importantly, the vaccine also seemed to be safe and well-tolerated.
Share this Article
Comment on this Article
Recommended
Please to comment